Alzheimer’s disease‐associated post‐translational modifications of tau influence tau propagation

Background In Alzheimer’s disease (AD), tau accumulates with a stereotyped progressive involvement of brain regions. The cellular mechanism for this is the neuron‐to‐neuron propagation of tau, but the factors that influence tau propagation are not fully understood. We hypothesize that AD‐associated...

Full description

Saved in:
Bibliographic Details
Published inAlzheimer's & dementia Vol. 19; no. S13
Main Authors Dickson, John R, Fernandes, Analiese R, Sobolewski, Robert, Fan, Zhanyun, Hyman, Bradley T.
Format Journal Article
LanguageEnglish
Published 01.12.2023
Online AccessGet full text

Cover

Loading…
Abstract Background In Alzheimer’s disease (AD), tau accumulates with a stereotyped progressive involvement of brain regions. The cellular mechanism for this is the neuron‐to‐neuron propagation of tau, but the factors that influence tau propagation are not fully understood. We hypothesize that AD‐associated post‐translational modifications (PTMs) of tau reduce its propagation since lysines are critical for LRP1‐mediated tau uptake. Method A construct was designed to model tau propagation in Chinese hamster ovary (CHO) cells and allow identification of donor and recipient cells by immunocytochemistry and flow cytometry. In addition to the wildtype (WT) tau sequence, constructs were made with pseudophosphorylation and pseudoacetylation mutations corresponding to the phosphorylations and acetylations found on low molecular weight (LMW) and high molecular weight (HMW) tau species in AD brains. Additionally, individual PTM mimic mutations corresponding to PTMs of the LMW tau species were made. The constructs were transfected into CHO cells and tau propagation was assessed by flow cytometry after 48 hours. Statistical analysis was performed by ANOVA with adjustment for multiple comparisons. Result Tau propagation using this cell culture model was demonstrated by immunocytochemistry and flow cytometry. Comparison of the WT, LMW‐mimic (8D2Q mutant), and HMW‐mimic (20D3Q mutant) tau propagation constructs revealed that the 8D2Q and 20D3Q mutants displayed reduced tau propagation compared to WT by 23.7% (p = 0.0186) and 26.5% (p = 0.0087), respectively. Comparing the ten single mutant constructs to WT, T181D and T231D showed increased tau propagation by 20.3% (p = 0.0002) and 15.9% (p = 0.0094), respectively. Compared to WT, T217D, K281Q, K353Q, and S404D showed reduced tau propagation by 17.3% (p = 0.0030), 15.3% (p = 0.0123), 23.7% (p <0.0001), and 16.6% (p = 0.0046), respectively. Conclusion The mimics of AD‐associated tau PTMs found on LMW and HMW tau reduce tau propagation, consistent with the initial hypothesis. The impact of individual PTM mimics on tau propagation is variable, but notably both pseudoacetylation mimics reduce propagation, possibly due to lower affinity with LRP1. Understanding how AD‐associated tau PTMs impact tau propagation may suggest novel targets to slow the progression of AD pathology.
AbstractList Background In Alzheimer’s disease (AD), tau accumulates with a stereotyped progressive involvement of brain regions. The cellular mechanism for this is the neuron‐to‐neuron propagation of tau, but the factors that influence tau propagation are not fully understood. We hypothesize that AD‐associated post‐translational modifications (PTMs) of tau reduce its propagation since lysines are critical for LRP1‐mediated tau uptake. Method A construct was designed to model tau propagation in Chinese hamster ovary (CHO) cells and allow identification of donor and recipient cells by immunocytochemistry and flow cytometry. In addition to the wildtype (WT) tau sequence, constructs were made with pseudophosphorylation and pseudoacetylation mutations corresponding to the phosphorylations and acetylations found on low molecular weight (LMW) and high molecular weight (HMW) tau species in AD brains. Additionally, individual PTM mimic mutations corresponding to PTMs of the LMW tau species were made. The constructs were transfected into CHO cells and tau propagation was assessed by flow cytometry after 48 hours. Statistical analysis was performed by ANOVA with adjustment for multiple comparisons. Result Tau propagation using this cell culture model was demonstrated by immunocytochemistry and flow cytometry. Comparison of the WT, LMW‐mimic (8D2Q mutant), and HMW‐mimic (20D3Q mutant) tau propagation constructs revealed that the 8D2Q and 20D3Q mutants displayed reduced tau propagation compared to WT by 23.7% (p = 0.0186) and 26.5% (p = 0.0087), respectively. Comparing the ten single mutant constructs to WT, T181D and T231D showed increased tau propagation by 20.3% (p = 0.0002) and 15.9% (p = 0.0094), respectively. Compared to WT, T217D, K281Q, K353Q, and S404D showed reduced tau propagation by 17.3% (p = 0.0030), 15.3% (p = 0.0123), 23.7% (p <0.0001), and 16.6% (p = 0.0046), respectively. Conclusion The mimics of AD‐associated tau PTMs found on LMW and HMW tau reduce tau propagation, consistent with the initial hypothesis. The impact of individual PTM mimics on tau propagation is variable, but notably both pseudoacetylation mimics reduce propagation, possibly due to lower affinity with LRP1. Understanding how AD‐associated tau PTMs impact tau propagation may suggest novel targets to slow the progression of AD pathology.
Abstract Background In Alzheimer’s disease (AD), tau accumulates with a stereotyped progressive involvement of brain regions. The cellular mechanism for this is the neuron‐to‐neuron propagation of tau, but the factors that influence tau propagation are not fully understood. We hypothesize that AD‐associated post‐translational modifications (PTMs) of tau reduce its propagation since lysines are critical for LRP1‐mediated tau uptake. Method A construct was designed to model tau propagation in Chinese hamster ovary (CHO) cells and allow identification of donor and recipient cells by immunocytochemistry and flow cytometry. In addition to the wildtype (WT) tau sequence, constructs were made with pseudophosphorylation and pseudoacetylation mutations corresponding to the phosphorylations and acetylations found on low molecular weight (LMW) and high molecular weight (HMW) tau species in AD brains. Additionally, individual PTM mimic mutations corresponding to PTMs of the LMW tau species were made. The constructs were transfected into CHO cells and tau propagation was assessed by flow cytometry after 48 hours. Statistical analysis was performed by ANOVA with adjustment for multiple comparisons. Result Tau propagation using this cell culture model was demonstrated by immunocytochemistry and flow cytometry. Comparison of the WT, LMW‐mimic (8D2Q mutant), and HMW‐mimic (20D3Q mutant) tau propagation constructs revealed that the 8D2Q and 20D3Q mutants displayed reduced tau propagation compared to WT by 23.7% (p = 0.0186) and 26.5% (p = 0.0087), respectively. Comparing the ten single mutant constructs to WT, T181D and T231D showed increased tau propagation by 20.3% (p = 0.0002) and 15.9% (p = 0.0094), respectively. Compared to WT, T217D, K281Q, K353Q, and S404D showed reduced tau propagation by 17.3% (p = 0.0030), 15.3% (p = 0.0123), 23.7% (p <0.0001), and 16.6% (p = 0.0046), respectively. Conclusion The mimics of AD‐associated tau PTMs found on LMW and HMW tau reduce tau propagation, consistent with the initial hypothesis. The impact of individual PTM mimics on tau propagation is variable, but notably both pseudoacetylation mimics reduce propagation, possibly due to lower affinity with LRP1. Understanding how AD‐associated tau PTMs impact tau propagation may suggest novel targets to slow the progression of AD pathology.
Author Dickson, John R
Sobolewski, Robert
Fan, Zhanyun
Fernandes, Analiese R
Hyman, Bradley T.
Author_xml – sequence: 1
  givenname: John R
  surname: Dickson
  fullname: Dickson, John R
  email: John.Dickson@MGH.HARVARD.EDU
  organization: Massachusetts General Hospital, Boston, MA
– sequence: 2
  givenname: Analiese R
  surname: Fernandes
  fullname: Fernandes, Analiese R
  organization: Massachusetts General Hospital, Charlestown, MA
– sequence: 3
  givenname: Robert
  surname: Sobolewski
  fullname: Sobolewski, Robert
  organization: Massachusetts General Hospital, Boston, MA
– sequence: 4
  givenname: Zhanyun
  surname: Fan
  fullname: Fan, Zhanyun
  organization: Massachusetts General Hospital, Boston, MA
– sequence: 5
  givenname: Bradley T.
  surname: Hyman
  fullname: Hyman, Bradley T.
  organization: Massachusetts General Hospital, Boston, MA
BookMark eNp9kL9OwzAQhy1UJNrCwhNkRko5O3aTjFXFP6kSCyws0cU5g5EbR3YqRKc-Aiuv1yehtBUj093vp-9u-EZs0PqWGLvkMOEA4hrdegIFcMhP2JArJVIl8nLwt0_hjI1ifAeQUHA1ZGbm1m9klxS2m--YNDYSRtpuvjBGry321CSdj_2u6QO20WFvfYsuWfrGGqv3MSbeJD2uEtsat6JW0z51wXf4uifO2alBF-niOMfs-fbmaX6fLh7vHuazRao5z_KUk1GaBGRlU3KFmJdK8lxgrQUZMCUXzRQpQyNlLqdFUxCWUFMtM2pIijobs6vDXx18jIFM1QW7xPBZcah-DVU7Q9XB0A7mB_jDOvr8h6xmi5fjzQ8Aq3Bj
ContentType Journal Article
Copyright 2023 the Alzheimer's Association.
Copyright_xml – notice: 2023 the Alzheimer's Association.
DBID AAYXX
CITATION
DOI 10.1002/alz.080107
DatabaseName CrossRef
DatabaseTitle CrossRef
DatabaseTitleList
CrossRef
DeliveryMethod fulltext_linktorsrc
EISSN 1552-5279
EndPage n/a
ExternalDocumentID 10_1002_alz_080107
ALZ080107
Genre abstract
GroupedDBID ---
--K
--M
.~1
0R~
1B1
1OC
1~.
1~5
24P
33P
4.4
457
4G.
53G
5VS
7-5
71M
7RV
7X7
8FI
8FJ
8P~
AACTN
AAEDT
AAHHS
AAIKJ
AAKOC
AALRI
AANLZ
AAOAW
AAXLA
AAXUO
ABBQC
ABCQJ
ABCUV
ABIVO
ABJNI
ABMAC
ABMZM
ABUWG
ACCFJ
ACCZN
ACGFS
ACGOF
ACPOU
ACXQS
ADBBV
ADBTR
ADEZE
ADHUB
ADKYN
ADMUD
ADPDF
ADVLN
ADZMN
ADZOD
AEEZP
AEIGN
AEKER
AENEX
AEQDE
AEUYR
AEVXI
AFKRA
AFTJW
AGHFR
AGUBO
AGWIK
AGYEJ
AITUG
AIURR
AIWBW
AJBDE
AJOXV
AJRQY
AKRWK
ALMA_UNASSIGNED_HOLDINGS
ALUQN
AMFUW
AMRAJ
AMYDB
ANZVX
AZQEC
BENPR
BFHJK
BLXMC
C45
CCPQU
DCZOG
EBS
EJD
EMOBN
EO8
EO9
EP2
EP3
F5P
FDB
FEDTE
FIRID
FNPLU
FYUFA
G-Q
GBLVA
HMCUK
HVGLF
HX~
HZ~
IHE
J1W
K9-
LATKE
LEEKS
M0R
M41
MO0
MOBAO
N9A
NAPCQ
O-L
O9-
OAUVE
OVD
OVEED
OZT
P-8
P-9
P2P
PC.
PGMZT
PIMPY
PSYQQ
Q38
QTD
RIG
ROL
RPM
RPZ
SDF
SDG
SEL
SES
SSZ
SUPJJ
T5K
TEORI
UKHRP
~G-
AAYXX
CITATION
ID FETCH-LOGICAL-c1137-1ef5ce2039d915aa7954172abc2ef0f912d6ae3af447468d8ea90beb43ede42b3
ISSN 1552-5260
IngestDate Fri Aug 23 01:22:21 EDT 2024
Sat Aug 24 00:55:33 EDT 2024
IsDoiOpenAccess false
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue S13
Language English
LinkModel OpenURL
MergedId FETCHMERGED-LOGICAL-c1137-1ef5ce2039d915aa7954172abc2ef0f912d6ae3af447468d8ea90beb43ede42b3
OpenAccessLink https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/alz.080107
PageCount 1
ParticipantIDs crossref_primary_10_1002_alz_080107
wiley_primary_10_1002_alz_080107_ALZ080107
PublicationCentury 2000
PublicationDate December 2023
2023-12-00
PublicationDateYYYYMMDD 2023-12-01
PublicationDate_xml – month: 12
  year: 2023
  text: December 2023
PublicationDecade 2020
PublicationTitle Alzheimer's & dementia
PublicationYear 2023
SSID ssj0040815
Score 2.4286714
Snippet Background In Alzheimer’s disease (AD), tau accumulates with a stereotyped progressive involvement of brain regions. The cellular mechanism for this is the...
Abstract Background In Alzheimer’s disease (AD), tau accumulates with a stereotyped progressive involvement of brain regions. The cellular mechanism for this...
SourceID crossref
wiley
SourceType Aggregation Database
Publisher
Title Alzheimer’s disease‐associated post‐translational modifications of tau influence tau propagation
URI https://onlinelibrary.wiley.com/doi/abs/10.1002%2Falz.080107
Volume 19
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3NTtwwELa2y6WXiopW0NIqEj0hZUkcO8RHBIsQasuhUKFeIjsZq1ttN4jNHtgTj9Arr8eTMI4dJ9s_lV6izcQbJfN9Go8n4xlC3qm0UDTiOoyLmIasFDpUXOpQaq0EANOsKerz4WN6csFOL_nlYHDXy1pa1GpULH-7r-R_UEUZ4mp2yT4CWX9TFOBvxBePiDAe_wnjg-nyK0xM_xOXsiDm7RcXn8Qgnf7RsbwyGzxaeW0mqWkbCvxelSZnqMuLq-XCJGrZBibNGZpaND4dkN9-fgYT-TdEKpuI48Tb-6OJ38bf5On4b0ttDNs2RDYrAphDd_lTpaop2mDbWNumgPu_2ritCXffLGb90AVNemkgztpysxK2DQVG0JfZDjPeRIveBO2nr1-sv60mK6fLEfrBrpvuaoltP4r_eZytBvz-i732hKzhw3A-JGtnn8fjo3aaZ-hL8aYYr3sHX_uW7nV3XvF2-qufxn05XyfP3LojOLAkek4GMNsg2oN3f3s3Dxx17m9_dKQJDGlQskKXYIUuQaUDJEjg6dKc9ejyglwcj88PT0LXeCMs4jjZD2PQvAAaJaIUMZcS35-hoytVQUFHWsS0TCUkUjO2z9KszECKSIFiCZTAqEpekuGsmsEmCZTgIhM8EyUOTdJUGH814qaSXhalSm-RnVZB-ZWtr5LbSto0RzXmVo1bZLfR3V-G5B6xV48Z_Jo87Zi5TYb19QLeoJtZq7cO8AdGOn7Q
link.rule.ids 315,786,790,27955,27956
linkProvider Ovid
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Alzheimer%E2%80%99s+disease%E2%80%90associated+post%E2%80%90translational+modifications+of+tau+influence+tau+propagation&rft.jtitle=Alzheimer%27s+%26+dementia&rft.au=Dickson%2C+John+R&rft.au=Fernandes%2C+Analiese+R&rft.au=Sobolewski%2C+Robert&rft.au=Fan%2C+Zhanyun&rft.date=2023-12-01&rft.issn=1552-5260&rft.eissn=1552-5279&rft.volume=19&rft.epage=n%2Fa&rft_id=info:doi/10.1002%2Falz.080107&rft.externalDBID=10.1002%252Falz.080107&rft.externalDocID=ALZ080107
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1552-5260&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1552-5260&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1552-5260&client=summon